1h Free Analyst Time
The neuroscience antibodies and assays market is forecasted to grow by USD 2.20 billion during 2023-2028, accelerating at a CAGR of 9.64% during the forecast period. The report on the neuroscience antibodies and assays market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidences of neurological disorders, increasing initiatives and support from governments and healthcare organizations, and technological advances in antibody manufacturing.
The neuroscience antibodies and assays market is segmented as below:
By Type
- Consumables
- Instruments
By Application
- Pharmaceutical and biopharmaceutical companies
- Academic and research institutes
- Hospital and diagnostic centers
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the neuroscience antibodies and assays market covers the following areas:
- Neuroscience antibodies and assays market sizing
- Neuroscience antibodies and assays market forecast
- Neuroscience antibodies and assays market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The analyst recognizes the following companies as the key players in the global neuroscience antibodies and assays market: Abcam plc, Abnova Corp., Bio Rad Laboratories Inc., Biosensis Pty Ltd., BMG LABTECH GmbH, Cell Signaling Technology Inc., Chemie Brunschwig AG, Elabscience Biotechnology Inc., Enzo Biochem Inc., F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., GenScript Biotech Corp., Kaneka Corp., Merck KGaA, NSJ Bioreagents, PerkinElmer Inc., Proteintech Group Inc., Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., and Thermo Fisher Scientific Inc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increasing clinical trials.'
According to the report, one of the major drivers for this market is the increasing incidences of neurological disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abcam plc
- Abnova Corp.
- Bio Rad Laboratories Inc.
- Biosensis Pty Ltd.
- BMG LABTECH GmbH
- Cell Signaling Technology Inc.
- Chemie Brunschwig AG
- Elabscience Biotechnology Inc.
- Enzo Biochem Inc.
- F. Hoffmann La Roche Ltd.
- Fujirebio Holdings Inc.
- GenScript Biotech Corp.
- Kaneka Corp.
- Merck KGaA
- NSJ Bioreagents
- PerkinElmer Inc.
- Proteintech Group Inc.
- Rockland Immunochemicals Inc.
- Santa Cruz Biotechnology Inc.
- Thermo Fisher Scientific Inc.
